Next Article in Journal
Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease: A Secondary Analysis Using TONIC Trial Data
Next Article in Special Issue
Safety of Oral Food Challenges in Early Life
Previous Article in Journal
Development of the Mental Synthesis Evaluation Checklist (MSEC): A Parent-Report Tool for Mental Synthesis Ability Assessment in Children with Language Delay
Previous Article in Special Issue
Anti-Epileptic Drug Toxicity in Children
Open AccessArticle

Efficacy, Safety, and Usability of Remifentanil as Premedication for INSURE in Preterm Neonates

1
Albany Medical College, Albany, NY 12208, USA
2
Department of Pediatrics, Albany Medical College, MC-101, 47 New Scotland Avenue, Albany, NY 12208, USA
*
Author to whom correspondence should be addressed.
Children 2018, 5(5), 63; https://doi.org/10.3390/children5050063
Received: 24 April 2018 / Revised: 15 May 2018 / Accepted: 19 May 2018 / Published: 22 May 2018
(This article belongs to the Special Issue 5th Anniversary Issue)
Background: We previously reported a 67% extubation failure with INSURE (Intubation, Surfactant, Extubation) using morphine as analgosedative premedication. Remifentanil, a rapid- and short-acting narcotic, might be ideal for INSURE, but efficacy and safety data for this indication are limited. Objectives: To assess whether remifentanil premedication increases extubation success rates compared with morphine, and to evaluate remifentanil’s safety and usability in a teaching hospital context. Methods: Retrospective review of remifentanil orders for premedication, at a large teaching hospital neonatal intensive care unit (NICU). We compared INSURE failure rates (needing invasive ventilation after INSURE) with prior morphine-associated rates. Additionally, we surveyed NICU staff to identify usability and logistic issues with remifentanil. Results: 73 remifentanil doses were administered to 62 neonates (mean 31.6 ± 3.8 weeks’ gestation). Extubation was successful in 88%, vs. 33% with morphine premedication (p < 0.001). Significant adverse events included chest wall rigidity (4%), one case of cardiopulmonary resuscitation (CPR) post-surfactant, naloxone reversal (5%), and notable transient desaturation (34%). Among 137 completed surveys, 57% indicated concerns, including delayed drug availability (median 1.1 h after order), rapid desaturations narrowing intubation timeframes and hindering trainee involvement, and difficulty with bag-mask ventilation after unsuccessful intubation attempts. Accordingly, 33% of ultimate intubators were attending neonatologists, versus 16% trainees. Conclusions: Remifentanil premedication was superior to morphine in allowing successful extubation, despite occasional chest wall rigidity and unfavorable conditions for trainees. We recommend direct supervision and INSURE protocols aimed at ensuring rapid intubation. View Full-Text
Keywords: remifentanil; INSURE; intubation; surfactant; sedation; premedication remifentanil; INSURE; intubation; surfactant; sedation; premedication
Show Figures

Figure 1

MDPI and ACS Style

Audil, H.Y.; Tse, S.; Pezzano, C.; Mitchell-van Steele, A.; Pinheiro, J.M.B. Efficacy, Safety, and Usability of Remifentanil as Premedication for INSURE in Preterm Neonates. Children 2018, 5, 63.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop